{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:52:17Z","timestamp":1771674737930,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.clindermatol.2009.06.020","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T11:03:08Z","timestamp":1276254188000},"page":"344-348","source":"Crossref","is-referenced-by-count":22,"title":["Severe cutaneous adverse drug reactions: who should treat, where and how?: Facts and controversies"],"prefix":"10.1016","volume":"28","author":[{"given":"Ronni","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batya","family":"Davidovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2009.06.020_bib1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2005.06721.x","article-title":"Toxic epidermal necrolysis: current evidence, practical management and future directions","volume":"153","author":"Chave","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1365-4362.1997.00100.x","article-title":"Toxic epidermal necrolysis\u2014a retrospective study","volume":"36","author":"Criton","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0305-4179(94)90072-8","article-title":"Lyell's syndrome on a burns unit","volume":"20","author":"Zoltie","year":"1994","journal-title":"Burns"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib6","first-page":"26","article-title":"Patients with acute skin loss: are they best managed on a burns unit?","volume":"83","author":"Hettiaratchy","year":"2001","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0305-4179(98)00191-0","article-title":"3rd. Treatment issues in the care of patients with toxic epidermal necrolysis","volume":"25","author":"Smoot","year":"1999","journal-title":"Burns"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.129.1.92","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.BCR.0000216532.71360.9B","article-title":"SCORTEN overestimates mortality in the setting of a standardized treatment protocol","volume":"27","author":"Imahara","year":"2006","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clindermatol.2004.03.016","article-title":"Treatment of toxic epidermal necrolysis syndrome with \u201cdisease-modifying\u201d drugs: the controversy goes on","volume":"22","author":"Wolf","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00006534-197861060-00021","article-title":"Toxic epidermal necrolysis. Case report","volume":"61","author":"Anhalt","year":"1978","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2340\/0001555553149152","article-title":"Fifteen cases of toxic epidermal necrolysis (Lyell)","volume":"53","author":"Bjornberg","year":"1973","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib14","first-page":"204","article-title":"Toxic epidermal necrolysis and Stevens-Johnson's disease","volume":"46","author":"Ohlenschlaeger","year":"1966","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0190-9622(85)80012-8","article-title":"Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid \u201cpulse therapy.","volume":"12","author":"Sherertz","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2500\/108854192778878926","article-title":"Stevens-Johnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS","volume":"13","author":"Patterson","year":"1992","journal-title":"Allergy Proc"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2500\/108854195778666793","article-title":"The outcome of Stevens-Johnson syndrome treated with corticosteroids","volume":"16","author":"Cheriyan","year":"1995","journal-title":"Allergy Proc"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2133.1993.tb00185.x","article-title":"Toxic epidermal necrolysis and systemic corticosteroids","volume":"128","author":"Stables","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2133.1976.tb00824.x","article-title":"Erythema multiforme in children. Response to treatment with systemic corticosteroids","volume":"95","author":"Rasmussen","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archderm.111.9.1135","article-title":"Toxic epidermal necrolysis. A review of 75 cases in children","volume":"111","author":"Rasmussen","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00004630-198305000-00005","article-title":"A burn center experience with toxic epidermal necrolysis","volume":"4","author":"Halebian","year":"1983","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.me.40.020189.001033","article-title":"Burn unit treatment of acute, severe exfoliating disorders","volume":"40","author":"Halebian","year":"1989","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3468(89)80240-4","article-title":"Drug-induced toxic epidermal necrolysis in children","volume":"24","author":"Jones","year":"1989","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib25","first-page":"273","article-title":"Burn center care for patients with toxic epidermal necrolysis","volume":"180","author":"Kelemen","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib26","first-page":"340","article-title":"Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids","volume":"180","author":"Herndon","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004630-199920060-00012","article-title":"Management of severe toxic epidermal necrolysis in children","volume":"20","author":"Sheridan","year":"1999","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1365-2230.2001.00910.x","article-title":"Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam","volume":"26","author":"van der Meer","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib29","first-page":"123","article-title":"Toxic epidermal necrolysis\/Stevens Johnson syndrome: positive outcome after treatment with dexamethasone pulse therapy","author":"Kardaun","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-0214","article-title":"Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"87","author":"Kardaun","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00128071-200607060-00004","article-title":"Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"7","author":"Mittmann","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.020_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.burns.2006.08.014","article-title":"Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis","volume":"33","author":"Stella","year":"2007","journal-title":"Burns"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:29:52Z","timestamp":1740176992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X09001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0738081X09001539"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2009.06.020","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}